ICD-10 Code K63.8212: Small intestinal bacterial overgrowth, hydrogen sulfide-subtype
What is this code?
ICD-10 codes are diagnosis classification codes used in healthcare records, reporting, coding workflows, and billing support. This code sits within the broader ICD-10 area for Diseases of the digestive system (K00-K95).
📋Clinical overview
Small intestinal bacterial overgrowth (SIBO) describes a clinically assessed disorder in which an altered bacterial population in the small intestine is linked to digestive symptoms or other findings. These pages distinguish hydrogen subtype, hydrogen-sulfide subtype and an unspecified subtype. Bloating or a code alone is not a diagnosis, and the label does not establish an acute contagious bowel infection, a particular organism or a guaranteed treatment response.
When is it used?
- May be used when a clinician documents small intestinal bacterial overgrowth, hydrogen sulfide-subtype in a patient's medical record.
- May appear in hospital records, claims, referrals, and clinical documentation.
- This code can be used as a clinically usable diagnosis entry in standardized coding workflows.
What it does not mean
- A code alone does not explain severity, treatment plan, or outcome.
- A medical code should not be treated as a substitute for a doctor's diagnosis or advice.
🩺Clinical context
- Records documenting SIBO after clinical assessment, rather than every episode of gas, abdominal discomfort or altered bowel habits.
- Symptoms can include bloating, abdominal pain, excess gas or diarrhea; other bowel symptoms can overlap with several digestive conditions. Symptoms alone do not identify a gas subtype or distinguish SIBO from all alternatives.
- Evaluation may consider bowel anatomy, prior abdominal surgery or changes in intestinal movement. The code does not prove that surgery, diabetes, a medicine or another particular condition caused the problem.
- Assessment reviews the symptom course, bowel habits, weight changes, diet, medicines and relevant surgery or digestive conditions. Other explanations for persistent symptoms may need investigation.
- Selected breath testing can help assess microbial overgrowth, but performance and interpretation are imperfect. Preparation, recent medicines, the test substrate, intestinal transit and the gases measured can affect the result.
- Follow the testing service's preparation instructions and discuss prescribed medicines before changing them. A single commercial breath or stool result should not be treated as a complete clinical diagnosis or a mandatory indication for antibiotics.
- If nutritional deficiency, malabsorption or a structural problem is suspected, the clinician may select additional blood, stool or imaging tests. This code does not establish vitamin deficiency or require every investigation for every patient.
- Treatment may include clinician-selected antibiotics and attention to contributing factors. The choice depends on the assessment, prior treatment and clinical circumstances; the code does not select a drug, dose or repeating course.
- Nutrition and dietary changes should address the person's actual needs. A dietitian may help when symptoms limit intake or nutritional problems are suspected; restrictive diets and supplements are not universal cures for bacterial overgrowth.
- Symptoms may recur after treatment. Persistent or returning symptoms need review of the diagnosis, underlying factors and response, rather than automatic repeated antibiotics or escalating a self-directed regimen.
- Ask what improvement is expected and what follow-up is appropriate. Neither symptom relief alone nor a change in a test number guarantees that every cause of the original symptoms has been addressed.
🔍Key distinctions
- SIBO, intestinal methanogen overgrowth and small intestinal fungal overgrowth are distinct recorded entities. Methanogens are not bacteria, and a methane-associated diagnosis must not be silently substituted for one of these bacterial codes.
- SIBO is not synonymous with irritable bowel syndrome, food intolerance or every symptom attributed to the microbiome. The clinical record and appropriately interpreted findings are needed to distinguish overlapping conditions.
- This explanation supplies no universal gas cutoff, mandatory test brand, low-FODMAP or low-sulfur protocol, probiotic prescription or guaranteed eradication claim. More restrictive treatment is not automatically better or safer.
- Sudden severe abdominal pain, vomiting blood, black sticky stools, heavy rectal bleeding or inability to pass stool or gas need emergency medical assessment. Do not attribute those symptoms to presumed SIBO; ongoing pain, weight loss or persistent bowel changes also need clinical review.
- Hydrogen sulfide-subtype preserves the specifically named form in the record. It is not the hydrogen subtype, intestinal methanogen overgrowth or fungal overgrowth. The label reveals no assay method, gas cutoff or validated treatment regimen, and does not prescribe a low-sulfur diet.
Code hierarchy
Where you may see this code
You may see this code in hospital records, discharge summaries, insurance claims, encounter documentation, referrals, or other healthcare billing and coding records.
Related specialists
Related codes
Sibling codes
Coverage-related procedures and services
Coding guidelines
Common synonyms
Frequently asked questions
About this content
This page is prepared by HealthAssure's clinical team using official coding standards from ICD-10. AI tools assist with drafting explanations, which are then reviewed and verified by healthcare professionals for accuracy. This content is for informational purposes and does not replace professional medical advice. Meet our team.